“���������������������������:za33���24������ ������������������������ ������”的搜索结果，显示 11-20 项，共有 962 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Go to page 2424 · Go to page 2525 · Go to page 2626 · NextNext Page · 申请预约 · 专长与排名研究. Dec. 24, 2024. 妙佑医疗国际明尼苏达州罗切斯特院区、妙佑医疗国际 ...

2. Ratio of 25OHD-to-2425OH2D A new test to confirm 24-hydroxylase CYP24A1 deficiency as the cause of hypercalcemia - 妙佑医疗国际

   clinical-trials. Ratio of 25OHD-to-2425OH2D A new test to confirm 24-hydroxylase CYP24A1 deficiency as the cause of hypercalcemia. MAC-20430939. 医疗专业人员 ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Go to page 2424 · Go to page 2525 · Go to page 2626 · NextNext Page · 申请预约 · 专长与排名研究. Dec. 24, 2024. 妙佑医疗国际明尼苏达州罗切斯特院区、妙佑医疗国际 ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

5. 妇产科- 临床试验- 妙佑医疗国际

   ... 24; Month 6) Visit 9 (Week 52; Month 12). Visit 10 (Week 104, Month 24). Predictive Role of Non-Invasive Glucose Assessment During Pregnancy. Rochester, Minn ...

6. 神经科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to assess the thalamus area of the brain using stereotactic electroencephalography (an EEG with deep electrode ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the safety and feasibility of the spinal array in treatment of patients with leptomeningeal metastases within the ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn., Jacksonville, Fla. The purpose of this study is to demonstrate pharmacokinetic non-inferiority for nivolumab + relatlimab FDC SC (fixed-dose ...

10. 外科 - 临床试验- 妙佑医疗国际

    ... 24; Month 6) Visit 9 (Week 52; Month 12). Visit 10 (Week 104, Month 24). Mayo Clinic Upper Digestive Disease Survey. Rochester, Minn. The Mayo Clinic Upper ...